Keith Chan Selected Research

Keith Chan Research Topics

8	Acquired Immunodeficiency Syndrome (AIDS) 10/2017 - 04/2008
3	Infections 06/2021 - 02/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2022
2	Abscess 01/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	HIV Infections (HIV Infection) 07/2012 - 03/2007
2	Wounds and Injuries (Trauma) 06/2010 - 05/2002
1	Cognitive Dysfunction 12/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2022
1	Ulcerative Colitis 06/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Fatigue 09/2017
1	Migraine Disorders (Migraine) 09/2017
1	Sleepiness 09/2017
1	Vomiting 09/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2017
1	Macular Degeneration (Age-Related Maculopathy) 11/2015
1	Smear Layer 05/2015
1	Mental Disorders (Mental Disorder) 11/2011
1	Femoral Fractures (Femoral Fracture) 06/2010
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2006
1	Disease Progression 02/2006
1	Alcoholism (Alcohol Abuse) 04/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2003
1	Needlestick Injuries (Needlestick Injury) 05/2002
1	Immune Reconstitution Inflammatory Syndrome 02/2002
1	Lymphadenitis (Adenitis) 02/2002

2	pembrolizumabIBA 01/2022 - 01/2018
2	cemiplimabIBA 01/2022 - 01/2022
2	NivolumabIBA 01/2021 - 12/2020
2	axicabtagene ciloleucelIBA 12/2020 - 01/2020
2	tisagenlecleucelIBA 12/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2013 - 04/2005
1	NeurotoxinsIBA 12/2022
1	LigandsIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	tofacitinibIBA 06/2021
1	vedolizumabIBA 06/2021
1	trametinibIBA 01/2021
1	InterferonsIBA 01/2021
1	IpilimumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	dabrafenibIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Irritants (Vesicants)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Brentuximab VedotinIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Tryptamines (Triptans)IBA 09/2017
1	almotriptan (Axert)FDA Link 09/2017
1	frovatriptan (Allegro)FDA Link 09/2017
1	human GAA protein (Myozyme)FDA Link 04/2017
1	afliberceptIBA 11/2015
1	Ranibizumab (Lucentis)FDA Link 11/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2014
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2010
1	NitritesIBA 03/2007
1	Vasodilator Agents (Vasodilators)IBA 03/2007
1	SmokeIBA 03/2006
1	VaccinesIBA 02/2005
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2002

11	Therapeutics 06/2021 - 05/2002
8	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 02/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Subcutaneous Injections 01/2021
1	Complementary Therapies (Alternative Medicine) 09/2017
1	Enzyme Replacement Therapy 04/2017
1	Lasers (Laser) 05/2015
1	Length of Stay 04/2003